Study AERD-COV19
Chronic use of aspirin as a prognostic factor for reduced susceptibility to SARS-CoV-2 infection in aspirin-exacerbated respiratory disease.
SINGLE-CENTER CLINICAL TRIAL
Sponsor:
Jagiellonian University Medical College
ul. Św. Anny 12, 31-008 Kraków
tel: +48 12 422 49 18
fax: +48 12 422 49 18
Login to the randomization system
For technical problems, please contact:
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
tel: 666 069 834
email: [email protected]
